New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alignment Healthcare, Inc.
ALHC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Medical - Healthcare Plans

Next Earning date - 29 Oct 2024

2B

Medical - Healthcare Plans

Next Earning date - 29 Oct 2024

11.04USD
Shape0.40 ( 3.76%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-51%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated October 27, 2024
1W 5.65 % 1M -6.60 % 3M 28.97 % 1Y 65.02 %

Key Metrics

Shape
  • Market Cap

    2.11B


  • Shares Outstanding

    191.30M


  • Share in Float

    86.93M


  • Dividende

    0


  • Earning Date

    29 Oct 2024


  • Price Target

    11.04


  • Average Volume

    1.20M


  • Beta

    1.47


  • Range

    4.46-12.36


  • Industry

    Medical - Healthcare Plans


  • Website

    https://www.alignmenthealthcare.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.95x

P/S Ratio

17.04x

P/B Ratio

1.7

Debt/Equity

-6.8%

Net Margin

$-0.8

EPS

How ALHC compares to sector?

P/E Ratio

Relative Strength

Shape

ALHC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape384%

2025-Revenue

$0.51

Shape-293%

2025-EPS

$186M

Shape-1481%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

KeyBanc

initialise

Previous: Not converted

2024-10-10

Now: Sector Weight

Raymond James

upgrade

Previous: Outperform

2023-10-16

Now: Strong Buy

UBS

initialise

Previous: Not converted

2023-10-12

Now: Buy

Needham

initialise

Previous: Not converted

2023-10-12

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.22
vs -0.26

Q4.22

arrow
arrow

N/A

-0.31
vs -0.27

Q1.23

arrow
arrow

N/A

-0.20
vs -0.23

Q2.23

arrow
arrow

N/A

-0.15
vs -0.06

Q3.23

arrow
arrow

N/A

-0.19
vs -0.22

Q4.23

arrow
arrow

N/A

-0.25
vs -0.31

Q1.24

arrow
arrow

N/A

-0.25
vs -0.20

Q2.24

arrow
arrow

N/A

-0.13
vs -0.15

Q3.24

arrow
arrow

N/A

-0.14
vs -0.19

Q4.24

arrow
arrow

N/A

-0.18
vs -0.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+23%

360.3M  vs 293.5M

Q4.22

arrow
arrow

+21%

361.8M  vs 298.3M

Q1.23

arrow
arrow

+27%

439.2M  vs 345.5M

Q2.23

arrow
arrow

+26%

462.4M  vs 366.5M

Q3.23

arrow
arrow

+27%

456.7M  vs 360.3M

Q4.23

arrow
arrow

+29%

465.4M  vs 361.8M

Q1.24

arrow
arrow

+43%

628.6M  vs 439.2M

Q2.24

arrow
arrow

+47%

681.3M  vs 462.4M

Q3.24

arrow
arrow

+45%

662.1M  vs 456.7M

Q4.24

arrow
arrow

+42%

660.9M  vs 465.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-15%

-0.15
vs -0.06

Q4.22

arrow
arrow

-24%

-0.24
vs -0.15

Q1.23

arrow
arrow

-17%

-0.17
vs -0.24

Q2.23

arrow
arrow

-14%

-0.14
vs -0.17

Q3.23

arrow
arrow

-19%

-0.19
vs -0.14

Q4.23

arrow
arrow

-30%

-0.30
vs -0.19

Q1.24

arrow
arrow

-36%

-0.36
vs -0.30

Q2.24

arrow
arrow

-19%

-0.19
vs -0.36

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

148

148
vs 91

63%

Q4.22

arrow
arrow

148

148
vs 148

NA

Q1.23

arrow
arrow

129

129
vs 148

-13%

Q2.23

arrow
arrow

142

142
vs 129

10%

Q3.23

arrow
arrow

131

131
vs 142

-8%

Q4.23

arrow
arrow

122

122
vs 131

-7%

Q1.24

arrow
arrow

131

131
vs 122

7%

Q2.24

arrow
arrow

118

118
vs 131

-10%

Earnings Growth

Latest News